02/10/2017
Natalia Perekhvatova, the CEO of Mitotech Ltd, discussed particulars of the mechanism of action of SkQ1 in treatingDry Eye Disease in a recent article by Fierce Biotech. You can access the full article here:
Natalia Perekhvatova, the CEO of Mitotech Ltd, discussed particulars of the mechanism of action of SkQ1 in treatingDry Eye Disease in a recent article by Fierce Biotech. You can access the full article here: